Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Superficial epidermolytic ichthyosis (SEI) is a rare keratinopathic ichthyosis (KI) characterized by the presence of superficial blisters and erosions at birth.
Features include: Congenital bullous ichthyosiform erythroderma.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 1 | Congenital bullous ichthyosiform erythroderma |
Pregnancy and birth | 1 | Congenital bullous ichthyosiform erythroderma |
KRT2 encodes keratin 2 (639 aa). Probably contributes to terminal cornification. Associated with keratinocyte activation, proliferation and keratinization. Highest expression in Skin Sun Exposed Lower leg (7,076 TPM) and Skin Not Sun Exposed Suprapubic (2,152 TPM).
Superficial epidermolytic ichthyosis is associated with mutations in the KRT2 gene on chromosome 12.
KRT2 is classified as a druggable target with score 0.0.
Genetic testing for KRT2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for superficial epidermolytic ichthyosis has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for superficial epidermolytic ichthyosis.
7 publications have been identified in PubMed for superficial epidermolytic ichthyosis. Research spans Case Report / Case Series (57%), Diagnostic / Biomarker (14%), and Review / Meta-Analysis (14%).
Bobica AC (2026). [PMID: 41244859](https://pubmed.ncbi.nlm.nih.gov/41244859/). *JAAD international*. [Diagnostic / Biomarker]
Saito N (2026). [PMID: 41589029](https://pubmed.ncbi.nlm.nih.gov/41589029/). *The Journal of dermatology*. [Case Report / Case Series]
Zaino M (2026). [PMID: 41782735](https://pubmed.ncbi.nlm.nih.gov/41782735/). *JAAD case reports*. [Case Report / Case Series]
Han JY (2025). [PMID: 40661104](https://pubmed.ncbi.nlm.nih.gov/40661104/). *JAAD case reports*. [Case Report / Case Series]
Xiang R (2025). [PMID: 40709761](https://pubmed.ncbi.nlm.nih.gov/40709761/). *Acta dermato-venereologica*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Wang C (2024). [PMID: 38489604](https://pubmed.ncbi.nlm.nih.gov/38489604/). *Dermatitis : contact, atopic, occupational, drug*. [Case Report / Case Series]